Document
Academic Article
Generically Dependent Continuant
RDF description of PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES. - http://irises.unibs.it/resource/item/39953
PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.
Article
Information Content Entity